Clinical Research Related Guidelines

This chapter provides an in-depth review of regulations governing clinical research, beginning with a historical understanding of these regulations as the result of ethical failures, and evolving to establish a global regulatory framework. It starts with establishing the ethical rationale for regulation, using historical events including the Nazi medical war crimes and the Tuskegee Syphilis Study that illuminated the ethical failures, resulting in the Nuremberg Code and the Belmont Report. The chapter dissects the ethical principle like Respect for Persons, Beneficence (minimize harm, promote welfare) and Justice to explicate how they can be applied within International Council for Harmonisation-Good Clinical Practice (ICH-GCP) guidelines. Essential components of participant protections including the informed consent process, monitoring participant safety, and data integrity (ALCOA+) are examined within an interdependent system. In addition to exploring regulatory implications of a global standard in clinical research, it will use the regulatory context in India as a case to demonstrate how global regulations are enacted at the country-level. Finally, the chapter provides a contemporary view of two current challenges; and the challenges between new adaptive and decentralized trial design, on one hand, and the evolving regulatory guidance around novel adjudication of ethics within research and ethics review boards, on the other. Overall, it is a look into a future of clinical research regulation that offers a more collaborative view of ethics and protects subjects equally in both the traditional and new innovative format.